Eligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity

被引：0
|
作者：
Chetty, Ashwin K. [1 ]
Khunte, Mihir [2 ]
Chen, Alissa S. [3 ]
Jastreboff, Ania M. [4 ]
Krumholz, Harlan M. [5 ]
Lu, Yuan [5 ]
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Brown Univ, Warren Alpert Med Sch, Providence, RI USA
[3] Yale Sch Med, Dept Internal Med, Natl Clinician Scholars Program, New Haven, CT USA
[4] Yale Sch Med, Yale Obes Res Ctr Y Weight, Dept Internal Med Endocrinol, New Haven, CT USA
[5] Yale New Haven Hosp, Ctr Outcomes Res & Evaluat, New Haven, CT 06510 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2024年
关键词：
D O I：
10.1007/s11606-024-09178-8
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1467 / 1469
页数：3
相关论文
共 50 条
  • [31] Recent achievements and future directions of anti-obesity medications
    Grandl, Gerald
    Novikoff, Aaron
    Liu, Xue
    Mueller, Timo D.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 47
  • [32] MODELLING LONG-TERM OUTCOMES OF TIRZEPATIDE COMPARED TO LIFESTYLE MODIFICATION AND OTHER ANTI-OBESITY MEDICATIONS AS TREATMENT FOR OVERWEIGHT AND OBESITY
    Hoog, M.
    Kan, H.
    Deger, K.
    Sorensen, S.
    Neff, L.
    Bae, J.
    Hankosky, E. R.
    Mojdami, D.
    White, B.
    Harris, M.
    VALUE IN HEALTH, 2023, 26 (06) : S24 - S24
  • [33] Body Weight Reduction with Anti-Obesity Medication? Drug Therapy of Overweight and Obesity
    Smollich, Martin
    AKTUELLE ERNAHRUNGSMEDIZIN, 2021, 46 (01): : 41 - 55
  • [34] Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform
    Inmaculada Hernandez
    Davene R. Wright
    Jingchuan Guo
    William H. Shrank
    Journal of General Internal Medicine, 2024, 39 : 306 - 308
  • [35] Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform
    Hernandez, Inmaculada
    Wright, Davene R.
    Guo, Jingchuan
    Shrank, William H.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (02) : 306 - 308
  • [36] PATTERNS OF COLORECTAL CANCER SCREENING AND OBESITY AMONG MEDICARE BENEFICIARIES
    Kendall, K. A.
    Lee, E.
    Zuckerman, I. H.
    Simoni-Wastila, L.
    Daniel, M.
    Green, P. M.
    Adderley-Kelly, B.
    Wutoh, A. K.
    VALUE IN HEALTH, 2009, 12 (07) : A261 - A261
  • [37] ANTI-OBESITY MEDICATIONS ARE UNDERUTILIZED IN TERTIARY ACADEMIC NAFLD CLINIC
    Petrie, Erin
    Aryan, Mahmoud
    Ousley, Robert
    Massoud, Moustafa
    Ravi, Sujan
    Beasley, Mark
    Shoreibah, Mohamed
    Gray, Meagan
    GASTROENTEROLOGY, 2022, 162 (07) : S1272 - S1272
  • [38] PRIMARY CARE PERSPECTIVES ON PRESCRIBING ANTI-OBESITY MEDICATIONS FOR ADOLESCENTS
    Chivate, Rutha
    Schoemer, Pamela
    Ray, Kristin
    Ragavan, Maya
    Bensignor, Megan
    Goldschmidt, Andrea
    Vajravelu, Mary Ellen
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 268 - 270
  • [39] Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease
    Stergios A. Polyzos
    Dimitrios G. Goulis
    Olga Giouleme
    Georgios S. Germanidis
    Antonis Goulas
    Current Obesity Reports, 2022, 11 : 166 - 179
  • [40] Why are we still in need for novel anti-obesity medications?
    Novikoff, Aaron
    Grandl, Gerald
    Liu, Xue
    Mueller, Timo D.
    LANCET REGIONAL HEALTH-EUROPE, 2024, 47
12345